After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Allogene Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Allogene Therapeutics Inc is $492.73M. A total of 3.56 million shares were traded on the day, compared to an average of 2.47M shares.
In the most recent transaction, MESSEMER DEBORAH M. sold 9,136 shares of ALLO for 2.18 per share on Dec 09 ’24. After the transaction, the Director now owns 157,629 company shares. In a previous transaction on Dec 05 ’24, Humer Franz B sold 9,221 shares at 2.16 per share. ALLO shares that Director owns now total 307,507.
Among the insiders who bought shares, MESSEMER DEBORAH M. acquired of 9,136 shares on Dec 09 ’24 at a per-share price of $2.18. In another insider transaction, Humer Franz B bought 9,221 shares at $2.48 per share on Dec 03 ’24.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, ALLO has a high of $5.78 and a low of $1.78.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ALLO’s latest balance sheet shows that the firm has $457.30M in Cash & Short Term Investments as of fiscal 2021. There were $73.13M in debt and $47.91M in liabilities at the time. Its Book Value Per Share was $2.21, while its Total Shareholder’s Equity was $925.20M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ALLO is Buy with a score of 4.35.
